Edwards Lifesciences Corp.
Sector and Industry
Healthcare, Healthcare Equipment
Performance (1Y)
10.13%
Market Cap
43.14 Bil.
P/E Ratio
47.11
Dividend Yield
0.00 %
Earnings per Share
1.60 €
Peer Group
| Company Name | Market Cap | Revenue Last Reported Year | P/E Ratio | Profit Growth 1Y | Last Price | Previous Trading Day Change |
|---|---|---|---|---|---|---|
| Abbott Laboratories | 185.26 Bil. | 39.29 Bil. | 33.69 | -53.32 % | 0.00 | - |
| Intuitive Surgical Inc | 171.24 Bil. | 8.92 Bil. | 71.93 | +17.90 % | 0.00 | - |
| Boston Scientific Corp | 120.40 Bil. | 17.79 Bil. | 49.17 | +49.88 % | 0.00 | - |
| Stryker Corp. | 114.47 Bil. | 22.26 Bil. | 41.85 | +3.99 % | 0.00 | - |
| Medtronic PLC | 94.91 Bil. | 31.13 Bil. | 23.29 | +27.43 % | 0.00 | - |
| Siemens Healthineers AG | 51.40 Bil. | 23.38 Bil. | 24.04 | +10.40 % | 0.00 | - |
| Hoya Corp | 48.59 Bil. | 5.43 Bil. | 35.69 | +17.33 % | 0.00 | - |
| Becton Dickinson and Co. | 45.46 Bil. | 19.79 Bil. | 32.18 | -3.33 % | 0.00 | - |
| Edwards Lifesciences Corp | 42.15 Bil. | 5.38 Bil. | 47.11 | -27.44 % | 0.00 | - |
| Alcon AG | 33.20 Bil. | 9.24 Bil. | 38.41 | -7.56 % | 0.00 | - |
Facts & figures
Price data
| TRADE PLATFORM | Börse Stuttgart (XSTU) | |
| LAST PRICE | 74.08 G | 0 Units |
| PRICE DETERMINATION TIME | 06/03/2026 / 09:56:48 PM | |
| DAILY VOLUME (UNITS) | 12 | |
| DAILY HIGH / LOW | 75.46 | 73.96 |
| PREV. DAY'S PRICE | 74.92 | (06/02) |
| CHANGE DAY BEFORE | -0.84 | -1.12 % |
| 52 WEEK HIGH / LOW | 76.48 (06/01) | 61.41 (10/17) |
Key Figures (in EUR)
| 2027e | 2026e | 2025 | 2024 | 2023 | |
|---|---|---|---|---|---|
| EARNINGS PER SHARE | 2.89 | 2.57 | 1.60 | 1.35 | 2.13 |
| DIVIDENDS PER SHARE | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| DIVIDEND YIELD IN % | - | - | 0.00 % | 0.00 % | 0.00 % |
| DIVIDEND GROWTH IN % | - | - | - | - | - |
| PRICE - EARNINGS RATIO | 25.46 | 28.65 | 47.11 | 50.73 | 33.13 |
| PRICE - BOOK RATIO | - | - | 4.79 | 4.36 | 6.89 |
| PRICE - SALES RATIO | - | - | 8.23 | 8.16 | 7.74 |
| PRICE - CASH FLOW RATIO | - | - | 31.31 | 81.81 | 51.87 |
Master Data
| WKN | 936853 |
| ISIN | US28176E1082 |
| SYMBOL | EWL |
| EXCHANGE SEGMENT | Freiverkehr |
| TYPE OF FINANCIAL INSTRUMENT | Equity |
| DENOMINATION | Edwards Lifesciences |
| INDEX MEMBERSHIP | - |
| TRADING SEGMENT | - |
| TRADING HOURS | 07:30:00 AM - 10:00:00 PM |
| TRADING CURRENCY | Euro |
| NOMINAL CURRENCY | US Dollar |
| SETTLEMENT CURRENCY | Euro |
| SECTOR AND INDUSTRY | Healthcare, Healthcare Equipment |
| NUMBER OF SHARES | 575.80 Mil. |
| MARKET CAPITALISATION | 43.14 Bil. |
Performance overview
| 1W | 1M | 3M | 6M | 1Y | 3Y | 5Y | YTD | |
|---|---|---|---|---|---|---|---|---|
| PERFORMANCE | -0.43 % | 5.64 % | 0.51 % | 3.14 % | 10.13 % | -5.90 % | -1.86 % | 2.07 % |
| HIGH | 76.48 | 76.48 | 76.48 | 76.48 | 76.48 | 88.38 | 118.62 | 76.48 |
| LOW | 73.42 | 64.98 | 64.98 | 63.33 | 61.41 | 54.55 | 54.55 | 63.33 |
Dividend
per share
Edwards Lifesciences does not deliver dividend information
Company profile
Edwards Lifesciences Corp. engages in patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart, and Critical Care. It operates through the following geographical segments: United States, Europe, Japan, and Rest of World. The company was founded by Miles Lowell Edwards in 1958 and is headquartered in Irvine, CA.
Structured products for Edwards Lifesciences Corp.
Analyst Rating
Ø-Target Price DistanceNot Available
Current Price
Not AvailableØ-Target Price
Not AvailableAverage ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0
Company Events
No company events available.